Literature DB >> 15111486

Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome.

Karen L Cheal1, Fahim Abbasi, Cindy Lamendola, Tracey McLaughlin, Gerald M Reaven, Earl S Ford.   

Abstract

The Adult Treatment Panel III (ATP III) has published criteria for diagnosing the metabolic syndrome, a cluster of closely related abnormalities related to insulin resistance that increase cardiovascular disease risk. The present analysis was performed to evaluate the ability of these criteria to identify insulin-resistant individuals. The population consisted of 443 healthy volunteers, with measurements of BMI, blood pressure, fasting plasma glucose, triglycerides, HDL cholesterol concentrations, and steady-state plasma glucose (SSPG) concentration. Insulin resistance was defined as being in the top tertile of SSPG concentrations. Of the population, 20% satisfied ATP III criteria for the metabolic syndrome. Although insulin resistance and the presence of the metabolic syndrome were significantly associated (P < 0.001), the sensitivity and positive predictive value equaled 46% (69 of 149) and 76% (69 of 91), respectively. Being overweight, with high triglycerides, low HDL cholesterol, or elevated blood pressure, most often resulted in a diagnosis of the metabolic syndrome. Thus, the ATP III criteria do not provide a sensitive approach to identifying insulin-resistant individuals. The individual components vary both in terms of their utility in making a diagnosis of the metabolic syndrome and their relationship to insulin resistance, with the obesity and lipid criteria being most useful.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15111486     DOI: 10.2337/diabetes.53.5.1195

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  58 in total

1.  Insulin resistance is not necessarily an essential element of metabolic syndrome.

Authors:  Rudruidee Karnchanasorn; Horng-Yi Ou; Lee-Ming Chuang; Ken C Chiu
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

2.  World Health Organization-defined metabolic syndrome is a better predictor of coronary calcium than the adult treatment panel III criteria in American men aged 40-49 years.

Authors:  Tomoko Takamiya; Wahid R Zaky; Daniel Edmundowics; Takashi Kadowaki; Hirotsugu Ueshima; Lewis H Kuller; Akira Sekikawa
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

3.  Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.

Authors:  G Marchesini; S Avagnina; E G Barantani; A M Ciccarone; F Corica; E Dall'Aglio; R Dalle Grave; P S Morpurgo; F Tomasi; E Vitacolonna
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

Review 4.  Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis.

Authors:  Katherine P Liao; Daniel H Solomon
Journal:  Rheumatology (Oxford)       Date:  2012-09-16       Impact factor: 7.580

Review 5.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

Review 6.  Managing cardiovascular risk in overweight children and adolescents.

Authors:  Sarita Dhuper; Sujatha Buddhe; Sunil Patel
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

7.  Diagnosis of insulin resistance in hypertensive patients by the metabolic syndrome: AHA vs. IDF definitions.

Authors:  C-M Hwu; C A Hsiung; K-D Wu; W-J Lee; K-C Shih; J Grove; Y-D I Chen; B L Rodriguez; J D Curb
Journal:  Int J Clin Pract       Date:  2008-06-28       Impact factor: 2.503

8.  High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

Authors:  Jean-Marc Sabaté; Pauline Jouët; Florence Harnois; Charlotte Mechler; Simon Msika; Maggy Grossin; Benoît Coffin
Journal:  Obes Surg       Date:  2008-02-20       Impact factor: 4.129

9.  Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007).

Authors:  Alireza Esteghamati; Haleh Ashraf; Omid Khalilzadeh; Ali Zandieh; Manouchehr Nakhjavani; Armin Rashidi; Mehrdad Haghazali; Fereshteh Asgari
Journal:  Nutr Metab (Lond)       Date:  2010-04-07       Impact factor: 4.169

10.  The Relationship between Lung Function and Metabolic Syndrome in Obese and Non-Obese Korean Adult Males.

Authors:  Soo Kyoung Kim; Kyu Yeon Hur; Yoon Ho Choi; Sun Wook Kim; Jae Hoon Chung; Hee Kyung Kim; Moon-Kyu Lee; Yong-Ki Min; Kwang-Won Kim; Jae Hyeon Kim
Journal:  Korean Diabetes J       Date:  2010-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.